WallStreetZenWallStreetZen

NASDAQ: IRIX
Iridex Corp Stock

$2.54+0.47 (+22.71%)
Updated Sep 29, 2023
IRIX Price
$2.54
Fair Value Price
$3.23
Market Cap
$41.22M
52 Week Low
$1.31
52 Week High
$2.74
P/E
-5.29x
P/B
3.06x
P/S
0.62x
PEG
N/A
Dividend Yield
N/A
Revenue
$56.39M
Earnings
-$7.77M
Gross Margin
43.3%
Operating Margin
-13.69%
Profit Margin
-13.8%
Debt to Equity
1.75
Operating Cash Flow
-$8M
Beta
0.86
Next Earnings
Nov 8, 2023
Ex-Dividend
N/A
Next Dividend
N/A

IRIX Overview

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IRIX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IRIX ($2.54) is undervalued by 21.37% relative to our estimate of its Fair Value price of $3.23 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
IRIX ($2.54) is significantly undervalued by 21.37% relative to our estimate of its Fair Value price of $3.23 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
IRIX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more IRIX due diligence checks available for Premium users.

Be the first to know about important IRIX news, forecast changes, insider trades & much more!

IRIX News

Valuation

IRIX fair value

Fair Value of IRIX stock based on Discounted Cash Flow (DCF)
Price
$2.54
Fair Value
$3.23
Undervalued by
21.37%
IRIX ($2.54) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
IRIX ($2.54) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
IRIX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IRIX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-5.29x
Industry
48.82x
Market
12.37x

IRIX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.06x
Industry
3.49x
IRIX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IRIX's financial health

Profit margin

Revenue
$12.9M
Net Income
-$2.8M
Profit Margin
-21.5%
IRIX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
IRIX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$36.9M
Liabilities
$23.5M
Debt to equity
1.75
IRIX's short-term assets ($30.97M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IRIX's short-term assets ($30.97M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IRIX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
IRIX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.1M
Investing
-$16.0k
Financing
-$63.0k
IRIX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IRIX vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
IRIX$41.22M+22.71%-5.29x3.06x
SONX$39.31M-1.84%-1.55x0.74x
OWLT$37.98M+8.47%-0.60x-1.39x
TLSI$37.86M-4.66%-34.13x-2.50x
EAR$45.05M-0.41%-0.22x0.75x

Iridex Stock FAQ

What is Iridex's quote symbol?

(NASDAQ: IRIX) Iridex trades on the NASDAQ under the ticker symbol IRIX. Iridex stock quotes can also be displayed as NASDAQ: IRIX.

If you're new to stock investing, here's how to buy Iridex stock.

What is the 52 week high and low for Iridex (NASDAQ: IRIX)?

(NASDAQ: IRIX) Iridex's 52-week high was $2.74, and its 52-week low was $1.31. It is currently -7.3% from its 52-week high and 93.89% from its 52-week low.

How much is Iridex stock worth today?

(NASDAQ: IRIX) Iridex currently has 16,229,103 outstanding shares. With Iridex stock trading at $2.54 per share, the total value of Iridex stock (market capitalization) is $41.22M.

Iridex stock was originally listed at a price of $7.63 in Dec 31, 1997. If you had invested in Iridex stock at $7.63, your return over the last 25 years would have been -66.69%, for an annualized return of -4.3% (not including any dividends or dividend reinvestments).

How much is Iridex's stock price per share?

(NASDAQ: IRIX) Iridex stock price per share is $2.54 today (as of Sep 29, 2023).

What is Iridex's Market Cap?

(NASDAQ: IRIX) Iridex's market cap is $41.22M, as of Oct 1, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Iridex's market cap is calculated by multiplying IRIX's current stock price of $2.54 by IRIX's total outstanding shares of 16,229,103.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.